Last verified: March 2026
56 Qualifying Conditions
Illinois recognizes 56 specific qualifying conditions for its medical cannabis program — one of the most expansive lists in the nation. The list has grown steadily since the original 2013 law, with the most recent additions coming in 2025.
| Condition | Category |
|---|---|
| AIDS / HIV | Immune |
| Agitation of Alzheimer's Disease | Neurological |
| ALS (Lou Gehrig's Disease) | Neurological |
| Arnold-Chiari Malformation | Neurological |
| Autism | Developmental |
| Cachexia / Wasting Syndrome | General |
| Cancer | Oncology |
| Causalgia | Pain |
| Chronic Inflammatory Demyelinating Polyneuropathy | Neurological |
| Chronic Pain | Pain |
| Complex Regional Pain Syndrome (CRPS) | Pain |
| Crohn's Disease | GI |
| CRPS (Type II) | Pain |
| Dystonia | Movement |
| Ehlers-Danlos Syndrome | Connective Tissue |
| Endometriosis | 2025 Addition |
| Epilepsy | Neurological |
| Female Orgasmic Disorder | 2025 Addition |
| Fibromyalgia | Pain |
| Fibrous Dysplasia | Bone |
| Glaucoma | Ocular |
| Hepatitis C | Liver |
| Huntington's Disease | Neurological |
| Hydrocephalus | Neurological |
| Inflammatory Bowel Disease (IBD) | GI |
| Interstitial Cystitis | Urological |
| Irritable Bowel Syndrome (IBS) | GI |
| Lupus | Autoimmune |
| Migraines | Pain |
| Multiple Sclerosis | Neurological |
| Muscular Dystrophy | Muscular |
| Myasthenia Gravis | Neurological |
| Myoclonus | Movement |
| Nail-Patella Syndrome | Genetic |
| Neurofibromatosis | Neurological |
| Neuropathy | Pain |
| Osteoarthritis | Joint |
| Ovarian Cysts | 2025 Addition |
| Parkinson's Disease | Neurological |
| Polycystic Kidney Disease | Renal |
| Post-Concussion Syndrome | Neurological |
| PTSD | Mental Health |
| Reflex Sympathetic Dystrophy | Pain |
| Residual Limb Pain | Pain |
| Rheumatoid Arthritis | Autoimmune |
| Seizure Disorders | Neurological |
| Sickle Cell Disease | Blood |
| Sjögren's Syndrome | Autoimmune |
| Spinal Cord Disease or Injury | Neurological |
| Spinocerebellar Ataxia | Neurological |
| Superior Canal Dehiscence Syndrome | ENT |
| Tarlov Cysts | Neurological |
| Terminal Illness (prognosis <6 months) | Palliative |
| Tourette Syndrome | Neurological |
| Traumatic Brain Injury (TBI) | Neurological |
| Uterine Fibroids | 2025 Addition |
2025 Additions
Illinois added four new conditions in 2025, all related to women's health: endometriosis, ovarian cysts, uterine fibroids, and female orgasmic disorder. These additions reflect growing recognition of cannabis therapy for conditions that disproportionately affect women and have historically been undertreated.
The OAPP Pathway
Even if your condition is not on the 56-item list, the Opioid Alternative Pilot Program (OAPP) provides a broad pathway. Under OAPP, anyone with a condition for which an opioid has been prescribed — or could be prescribed — qualifies for medical cannabis. This effectively covers virtually any significant pain condition. See our program overview for OAPP details.
If your condition is not among the 56 named qualifiers, check the OAPP pathway. If your doctor has prescribed or could prescribe an opioid for your condition, you likely qualify through the Opioid Alternative Pilot Program. This covers chronic pain, arthritis, back injuries, and many other conditions not explicitly listed.
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org